<DOC>
	<DOCNO>NCT00242320</DOCNO>
	<brief_summary>The aim study compare effect roflumilast lung function patient COPD . Roflumilast administer orally daily morning one dose level . The study duration consist baseline period ( 4 week ) treatment period ( 12 week ) . The study provide data safety tolerability roflumilast .</brief_summary>
	<brief_title>Efficacy Safety Oral Roflumilast Taken Once Daily Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease ( BY217/M2-119 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Main Written inform consent Patients history chronic obstructive pulmonary disease ( COPD ) define GOLD criterion ( 2003 ) FEV1/FVC ratio ( post bronchodilator ) small equal 70 % FEV1 ( post bronchodilator ) 3080 % predict Fixed airway obstruction Current smoker former smoker ( smoke cessation least one year ago ) smoke history least 10 pack year Clinically stable COPD within 4 week prior baseline visit Availability chest xray Main COPD exacerbation indicate treatment systemic glucocorticosteroids Lower respiratory tract infection Diagnosis asthma Known alpha1antitrypsin deficiency Need long term oxygen therapy define long equal 16 hours/day Clinically relevant abnormal laboratory value suggest unknown disease require clinical evaluation ( assessed investigator ) Known infection HIV , active hepatitis and/or liver insufficiency ( accord Child Pugh score A worse ) Diagnosis history cancer Clinically significant cardiopulmonary abnormality Pregnancy , breast feeding , oocyte donation oocyte implantation plan trial Female patient childbearing potential , use reliable method contraception entire study duration , postmenopausal &gt; 1 year use method consider sufficiently reliable investigator individual case Participation another study ( use investigational product ) within 30 day precede baseline visit reentry patient already enrol trial Alcohol drug abuse Inability follow study procedure due e.g. , language problem , physiological disorder Use allow drug Suspected hypersensitivity study medication rescue medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>Roflumilast</keyword>
</DOC>